HealthPartners Institute
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, HealthPartners Institute sits in the top decile of US sponsors by registered trial count (#191 of 15,742 sponsors by registered trial count).
HealthPartners Institute: 146 sponsored US clinical trials, 12 recruiting.
HealthPartners Institute sponsors 146 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 111 completed. 11 of these trials are in Phase 3-4 (later-stage) and 19 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 3 trials.
Top-decile sponsor footprint
HealthPartners Institute ranks in the top decile of sponsors by registered trial count (#191 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
111 of 126 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
146 total, page 2 of 3
IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase
NCT04028960
EMS Prehospital Blood Culture Collection and Antibiotic Administration: A Two-Phase Pilot Project to Reduce Mortality in Patients With Severe Sepsis and Septic Shock
NCT04134624
Intranasal Insulin in Frontotemporal Dementia (FTD)
NCT04115384
Lavender vs Zolpidem Sleep Quality During Diagnostic PSG
NCT04102345
Fuzzy Logic Automated Insulin Regulation
NCT03040414
Simulation of Adenosine Push Methods for Treatment of SVT Using Agitated Saline Visualized by Ultrasound
NCT04051541
Comprehensive Cardiac Rehabilitation Feasibility After Stroke
NCT03944668
Chronic Kidney Disease Clinical Decision Support
NCT03890588
Engaging Patients in Tobacco Cessation Resources in Dental Settings
NCT03656874
Effect of Prophylactic Negative Pressure Versus Silver Impregnated Silicone Bandage on C-Section Infection Rates
NCT04582045
Mindfulness Based Dementia Care Study
NCT04062227
Firefighter Cardiorespiratory Fitness (CRF) Pilot Study
NCT03585335
Cancer Prevention Clinical Decision Support
NCT02986230
Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy
NCT03657849
Clinical Decision Support for Opioid Use Disorders in Medical Settings: Usability Testing in an EMR
NCT03559179
Audio Distraction for Traction Pin Placement
NCT05927480
Prospective Single Center Randomized Double Blind Controlled Tolerability Trial of Six Hair Cleansing Conditioners
NCT03483025
Evaluation of a Quality Improvement Project on Impacted Fetal Head at Cesarean Section
NCT03387189
Pragmatic Trial Comparing Telehealth Care and Optimized Clinic-Based Care for Uncontrolled High Blood Pressure
NCT02996565
Esophageal Food Impaction
NCT03305848
The SIM-PLICITY Study: The SIMulation Project - LIstening & Intervention in Pediatric obeSITY
NCT02946515
EHR-based Decision Support for Pediatric Acute Abdominal Pain in Emergency Care
NCT02633735
Microbiome Changes in Severe Burns
NCT03130868
Tailored Self-Management of Temporomandibular Disorders (TMD) Using Health Information Technology
NCT03036215
Patient Knowledge of Medication Indication
NCT03125278
Single-Stage Integra Reconstruction in Burns
NCT03077087
Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal
NCT03064035
Peripheral Internal Jugular Vein ('Peripheral IJ') Access in Patients Identified as Difficult Intravenous Access
NCT03063996
Pre-Diabetes Cardiovascular (CV) Care (Pre-Diabetes Wizard)
NCT02759055
Olanzapine for Acute Headaches
NCT03066622
Reducing Cardiovascular Risk in Adults With Serious Mental Illness
NCT02451670
Mirabegron in Parkinson Disease and Impaired Cognition
NCT02536976
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
NCT02503501
Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut)
NCT02992327
Treatment of Hypertension In Adults With ThiaZIDES: Pragmatic Trial Pilot Study
NCT02591628
BestFIT: a Personalized Weight Loss Program
NCT02368002
Investigation of the Safety of Intranasal Glulisine in Down Syndrome
NCT02432716
Let's Play! Healthy Kids After Cancer
NCT02361047
Evaluating the Efficacy of Lateral Heel Wedges of Osteoarthritis of the Knee
NCT02254473
Superior Labral Tear From Anterior to Posterior (SLAP) Repair Versus Biceps Tenodesis for SLAP Tears in the Shoulder
NCT02296554
Electronic Health Record-Based Clinical Decision Support to Improve Blood Pressure Management in Adolescents
NCT01760239
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)
NCT02074384
Intraosseous Pressure Monitoring in Intensive Care Unit Patients
NCT02059928
Sub-dissociative Ketamine for the Management of Acute Pediatric Pain
NCT01951963
Continuous Lidocaine Infusion for Management of Perioperative Burn Pain
NCT02059902
Managing Diabetes Mindfully Study
NCT01796834
Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors
NCT01509079
SUPREME-DM (Diabetes Mellitis) Treatment Study
NCT02192255
Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.
NCT01436045
Rotator Cuff Repair Using Standard Double Row Technique With Platelet Rich Fibrin Membrane vs. Standard Double Row Technique
NCT02256891
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 12 |
| Phase 3 | 1 |
| Phase 4 | 10 |
What is open in the HealthPartners Institute pipeline
12 recruiting of 146 indexed (8% open); 111 completed (76%).
Phase mix: 11 late (III/IV) vs 19 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
HealthPartners Institute: open-pipeline peers nationwide
Peers matched on 146 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
HealthPartners Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 146 trials (± recruiting share)
- Mylan Pharmaceuticals · 146 trials · 1% recruiting
- SCRI Development Innovations · 146 trials · 3% recruiting
- Forest Laboratories · 145 trials · 0% recruiting
- National Institute of Environmental Health Sciences (NIEHS) · 145 trials · 10% recruiting
Sponsors near 8% open enrollment (± trial volume)
- National Eye Institute (NEI) · 8% recruiting · 221 trials
- Acrotech Biopharma · 8% recruiting · 24 trials
- Atlanta VA Medical Center · 8% recruiting · 12 trials
- Beacon Therapeutics · 8% recruiting · 12 trials
Related
What to do with this HealthPartners Institute page
146 registered trials is a research-attention snapshot, not an endorsement of HealthPartners Institute or any single study.
- 12 of HealthPartners Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition HealthPartners Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
HealthPartners Institute pipeline card: 146 registered trials from official public datasets.Report a data error.